{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,25]],"date-time":"2026-09-25T19:21:14Z","timestamp":1790364074314,"version":"4.1.0"},"reference-count":14,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2025,1,1]],"date-time":"2025-01-01T00:00:00Z","timestamp":1735689600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2025,1,1]],"date-time":"2025-01-01T00:00:00Z","timestamp":1735689600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2025,1,1]],"date-time":"2025-01-01T00:00:00Z","timestamp":1735689600000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-017"},{"start":{"date-parts":[[2025,1,1]],"date-time":"2025-01-01T00:00:00Z","timestamp":1735689600000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-037"},{"start":{"date-parts":[[2025,1,1]],"date-time":"2025-01-01T00:00:00Z","timestamp":1735689600000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-012"},{"start":{"date-parts":[[2025,1,1]],"date-time":"2025-01-01T00:00:00Z","timestamp":1735689600000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-029"},{"start":{"date-parts":[[2025,1,1]],"date-time":"2025-01-01T00:00:00Z","timestamp":1735689600000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-004"}],"funder":[{"DOI":"10.13039\/501100011198","name":"State Key Laboratory of Drug Research, Chinese Academy of Sciences","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100011198","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100001809","name":"National Natural Science Foundation of China","doi-asserted-by":"publisher","award":["82073924"],"award-info":[{"award-number":["82073924"]}],"id":[{"id":"10.13039\/501100001809","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Journal of Chromatography B"],"published-print":{"date-parts":[[2025,1]]},"DOI":"10.1016\/j.jchromb.2024.124396","type":"journal-article","created":{"date-parts":[[2024,11,30]],"date-time":"2024-11-30T03:40:06Z","timestamp":1732938006000},"page":"124396","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":7,"special_numbering":"C","title":["Quantification of crisugabalin (HSK16149) in biological matrix by LC-MS\/MS method: An application to rat pharmacokinetic and tissue distribution studies"],"prefix":"10.1016","volume":"1251","author":[{"given":"Zeyu","family":"Wang","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Pingming","family":"Tang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Caixia","family":"Dou","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jiale","family":"Shen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ni","family":"Peng","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yao","family":"Li","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ju","family":"Wang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Xiaoyan","family":"Chen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"issue":"3","key":"10.1016\/j.jchromb.2024.124396_b0005","doi-asserted-by":"crossref","first-page":"237","DOI":"10.1016\/j.pain.2007.08.033","article-title":"Pharmacologic management of neuropathic pain: Evidence-based recommendations","volume":"132","author":"Dworkin","year":"2007","journal-title":"Pain"},{"issue":"6","key":"10.1016\/j.jchromb.2024.124396_b0010","doi-asserted-by":"crossref","first-page":"350","DOI":"10.1097\/00002508-200211000-00002","article-title":"Epidemiology and impact on quality of life of postherpetic neuralgia and painful diabetic neuropathy","volume":"18","author":"Schmader","year":"2002","journal-title":"Clin. J Pain"},{"issue":"20","key":"10.1016\/j.jchromb.2024.124396_b0015","first-page":"10663","article-title":"Current views of diabetic peripheral neuropathic pain comorbid depression - a review","volume":"24","author":"Wei","year":"2020","journal-title":"Eur. Rev. Med. Pharmacol. Sci."},{"key":"10.1016\/j.jchromb.2024.124396_b0020","doi-asserted-by":"crossref","DOI":"10.1016\/j.diabres.2021.109063","article-title":"Screening, diagnosis and management of diabetic sensorimotor polyneuropathy in clinical practice: International expert consensus recommendations","volume":"186","author":"Ziegler","year":"2022","journal-title":"Diabetes Res. Clin. Pract."},{"issue":"864","key":"10.1016\/j.jchromb.2024.124396_b0025","doi-asserted-by":"crossref","first-page":"623","DOI":"10.1136\/pgmj.73.864.623","article-title":"The management of postherpetic neuralgia","volume":"73","author":"Bowsher","year":"1997","journal-title":"Postgrad. Med. J."},{"issue":"9","key":"10.1016\/j.jchromb.2024.124396_b0030","doi-asserted-by":"crossref","first-page":"307","DOI":"10.1007\/s11916-023-01146-x","article-title":"Therapeutic Strategies for Postherpetic Neuralgia: Mechanisms, Treatments, and Perspectives","volume":"27","author":"Tang","year":"2023","journal-title":"Curr. Pain Headache Rep."},{"issue":"8","key":"10.1016\/j.jchromb.2024.124396_b0035","doi-asserted-by":"crossref","first-page":"807","DOI":"10.1016\/S1474-4422(10)70143-5","article-title":"Neuropathic pain: diagnosis, pathophysiological mechanisms, and treatment","volume":"9","author":"Baron","year":"2010","journal-title":"Lancet Neurol."},{"issue":"11","key":"10.1016\/j.jchromb.2024.124396_b0040","doi-asserted-by":"crossref","first-page":"1153","DOI":"10.1111\/j.1468-1331.2006.01511.x","article-title":"EFNS guidelines on pharmacological treatment of neuropathic pain","volume":"13","author":"Attal","year":"2006","journal-title":"Eur. J. Neurol."},{"issue":"3","key":"10.1016\/j.jchromb.2024.124396_b0045","doi-asserted-by":"crossref","first-page":"330","DOI":"10.1124\/jpet.120.000315","article-title":"Pharmacology and Mechanism of Action of HSK16149, a Selective Ligand of \u03b12\u03b4 Subunit of Voltage-Gated Calcium Channel with Analgesic Activity in Animal Models of Chronic Pain","volume":"376","author":"Gou","year":"2021","journal-title":"J. Pharmacol. Exp. Ther."},{"key":"10.1016\/j.jchromb.2024.124396_b0050","doi-asserted-by":"crossref","DOI":"10.1007\/s12035-024-04424-w","article-title":"The Voltage-Gated Calcium Channel \u03b12\u03b4 Subunit in Neuropathic Pain","author":"Guo","year":"2024","journal-title":"Mol. Neurobiol."},{"key":"10.1016\/j.jchromb.2024.124396_b0055","doi-asserted-by":"crossref","DOI":"10.2337\/db23-224-OR","article-title":"The Efficacy and Safety of HSK 16149 in Chinese with Diabetic Peripheral Neuropathic Pain-A Randomized, Double-Blinded, Placebo and Pregabalin-Controlled Phase II\/III Study","volume":"72","author":"Guo","year":"2023","journal-title":"Diabetes"},{"key":"10.1016\/j.jchromb.2024.124396_b0060","doi-asserted-by":"crossref","DOI":"10.3389\/fphar.2023.1296672","article-title":"A phase I study to evaluate the safety, tolerability, and pharmacokinetics of a novel, potent GABA analog HSK16149 in healthy Chinese subjects","volume":"14","author":"Chen","year":"2023","journal-title":"Front. Pharmacol."},{"key":"10.1016\/j.jchromb.2024.124396_b0065","unstructured":"Bioanalytical Method Validation Guidance for Industry, U.S. Food and Drug Administration, 2018."},{"issue":"7","key":"10.1016\/j.jchromb.2024.124396_b0070","doi-asserted-by":"crossref","first-page":"1093","DOI":"10.1023\/A:1018943613122","article-title":"Physiological Parameters in Laboratory Animals and Humans","volume":"10","author":"Davies","year":"1993","journal-title":"Pharm. Res."}],"container-title":["Journal of Chromatography B"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1570023224004057?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1570023224004057?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,1,9]],"date-time":"2025-01-09T14:56:45Z","timestamp":1736434605000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S1570023224004057"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,1]]},"references-count":14,"alternative-id":["S1570023224004057"],"URL":"https:\/\/doi.org\/10.1016\/j.jchromb.2024.124396","relation":{},"ISSN":["1570-0232"],"issn-type":[{"value":"1570-0232","type":"print"}],"subject":[],"published":{"date-parts":[[2025,1]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Quantification of crisugabalin (HSK16149) in biological matrix by LC-MS\/MS method: An application to rat pharmacokinetic and tissue distribution studies","name":"articletitle","label":"Article Title"},{"value":"Journal of Chromatography B","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.jchromb.2024.124396","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2024 Elsevier B.V. All rights are reserved, including those for text and data mining, AI training, and similar technologies.","name":"copyright","label":"Copyright"}],"article-number":"124396"}}